Copyright Reports & Markets. All rights reserved.

Global and United States Precision Cancer Therapies Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Hormone Therapy
    • 1.2.3 Immunotherapies
    • 1.2.4 Targeted Therapy
    • 1.2.5 Monoclonal Antibody Therapy
    • 1.2.6 Gene Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Precision Cancer Therapies Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Diagnostic Centers
    • 1.3.4 Oncology Clinics
    • 1.3.5 Research Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Precision Cancer Therapies Market Perspective (2015-2026)
  • 2.2 Global Precision Cancer Therapies Growth Trends by Regions
    • 2.2.1 Precision Cancer Therapies Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Precision Cancer Therapies Historic Market Share by Regions (2015-2020)
    • 2.2.3 Precision Cancer Therapies Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Precision Cancer Therapies Players by Market Size
    • 3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2015-2020)
    • 3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2015-2020)
  • 3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
  • 3.4 Global Precision Cancer Therapies Market Concentration Ratio
    • 3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2019
  • 3.5 Key Players Precision Cancer Therapies Area Served
  • 3.6 Key Players Precision Cancer Therapies Product Solution and Service
  • 3.7 Date of Enter into Precision Cancer Therapies Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Therapies Breakdown Data by Type (2015-2026)

  • 4.1 Global Precision Cancer Therapies Historic Market Size by Type (2015-2020)
  • 4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2021-2026)

5 Precision Cancer Therapies Breakdown Data by Application (2015-2026)

  • 5.1 Global Precision Cancer Therapies Historic Market Size by Application (2015-2020)
  • 5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Precision Cancer Therapies Market Size (2015-2026)
  • 6.2 North America Precision Cancer Therapies Market Size by Type (2015-2020)
  • 6.3 North America Precision Cancer Therapies Market Size by Application (2015-2020)
  • 6.4 North America Precision Cancer Therapies Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Precision Cancer Therapies Market Size (2015-2026)
  • 7.2 Europe Precision Cancer Therapies Market Size by Type (2015-2020)
  • 7.3 Europe Precision Cancer Therapies Market Size by Application (2015-2020)
  • 7.4 Europe Precision Cancer Therapies Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Precision Cancer Therapies Market Size (2015-2026)
  • 8.2 China Precision Cancer Therapies Market Size by Type (2015-2020)
  • 8.3 China Precision Cancer Therapies Market Size by Application (2015-2020)
  • 8.4 China Precision Cancer Therapies Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Precision Cancer Therapies Market Size (2015-2026)
  • 9.2 Japan Precision Cancer Therapies Market Size by Type (2015-2020)
  • 9.3 Japan Precision Cancer Therapies Market Size by Application (2015-2020)
  • 9.4 Japan Precision Cancer Therapies Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Precision Cancer Therapies Market Size (2015-2026)
  • 10.2 Southeast Asia Precision Cancer Therapies Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Precision Cancer Therapies Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Precision Cancer Therapies Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
    • 11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Bayer HealthCare
    • 11.2.1 Bayer HealthCare Company Details
    • 11.2.2 Bayer HealthCare Business Overview
    • 11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
    • 11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.2.5 Bayer HealthCare Recent Development
  • 11.3 GlaxoSmithKline
    • 11.3.1 GlaxoSmithKline Company Details
    • 11.3.2 GlaxoSmithKline Business Overview
    • 11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
    • 11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.3.5 GlaxoSmithKline Recent Development
  • 11.4 OncoGenex Pharmaceuticals
    • 11.4.1 OncoGenex Pharmaceuticals Company Details
    • 11.4.2 OncoGenex Pharmaceuticals Business Overview
    • 11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
    • 11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.4.5 OncoGenex Pharmaceuticals Recent Development
  • 11.5 Hospira
    • 11.5.1 Hospira Company Details
    • 11.5.2 Hospira Business Overview
    • 11.5.3 Hospira Precision Cancer Therapies Introduction
    • 11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.5.5 Hospira Recent Development
  • 11.6 Boehringer Ingelheim
    • 11.6.1 Boehringer Ingelheim Company Details
    • 11.6.2 Boehringer Ingelheim Business Overview
    • 11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
    • 11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.6.5 Boehringer Ingelheim Recent Development
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Precision Cancer Therapies Introduction
    • 11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.7.5 AstraZeneca Recent Development
  • 11.8 Aveo Pharmaceuticals
    • 11.8.1 Aveo Pharmaceuticals Company Details
    • 11.8.2 Aveo Pharmaceuticals Business Overview
    • 11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
    • 11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020)
    • 11.8.5 Aveo Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Precision Cancer Therapies Scope and Market Size
    Precision Cancer Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Precision Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Hormone Therapy
    Immunotherapies
    Targeted Therapy
    Monoclonal Antibody Therapy
    Gene Therapy

    Market segment by Application, split into
    Hospitals
    Diagnostic Centers
    Oncology Clinics
    Research Institutes

    Based on regional and country-level analysis, the Precision Cancer Therapies market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Precision Cancer Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Bayer HealthCare
    GlaxoSmithKline
    OncoGenex Pharmaceuticals
    Hospira
    Boehringer Ingelheim
    AstraZeneca
    Aveo Pharmaceuticals

    Buy now